IPIX updated the 2/28/20 Shareholder Alert on 3/1/
Post# of 72446
(Total Views: 423)
Posted On: 03/02/2020 1:25:41 AM
IPIX updated the 2/28/20 Shareholder Alert on 3/1/20 on the IPIX web site. You can click on the attached link below or go to the IPIX website and click the tab on top "COVID-19" that has the PDF entitled "Brilacidin as a potential coronavirus treatment". There is up to date information on the COVID-19 virus and includes 2 review articles on coronaviruses suggesting immunomodulators, like Brilacidin, might be therapeutic options, potentially acting synergistically when combined with other antivirals. The following paragraph summarizes the benefits that Brilacidin offers to potentially combat the coronavirus outbreak.
"Computationally-modeled after natural Host Defense Proteins/Peptides (HDPs)1, the “front-line” of defense in the body's innate immune system, Brilacidin is a synthetic, non-peptidic small molecule that kills pathogens swiftly and effectively. Just as importantly, Brilacidin functions in a robust immunomodulatory capacity, lessening inflammation and promoting healing."
https://static1.squarespace.com/static/571535...update.pdf
"Computationally-modeled after natural Host Defense Proteins/Peptides (HDPs)1, the “front-line” of defense in the body's innate immune system, Brilacidin is a synthetic, non-peptidic small molecule that kills pathogens swiftly and effectively. Just as importantly, Brilacidin functions in a robust immunomodulatory capacity, lessening inflammation and promoting healing."
https://static1.squarespace.com/static/571535...update.pdf
(6)
(0)